Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.19.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Common Stock
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2017       24,766,892    
Beginning balance at Dec. 31, 2017 $ 33,695,145 $ 56,176,330 $ (165,317) $ 24,767 $ (22,796,246) $ 455,611
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Reclassification of Accumulated Other Comprehensive Loss     165,317   (165,317)  
Exercise of stock options (shares)       40,204    
Exercise of stock options 48,245 48,205   $ 40    
Stock issuance costs (553) (553)        
Distributions to Noncontrolling interests (6,957)         (6,957)
Stock based compensation expense 40,416 40,416        
Net income (loss) 20,759       20,759  
Net loss (16,381)          
Net income (loss) 37,140          
Ending balance (shares) at Mar. 31, 2018       24,807,096    
Ending balance at Mar. 31, 2018 33,797,055 56,264,398 0 $ 24,807 (22,940,804) 448,654
Beginning balance (shares) at Dec. 31, 2018       24,824,746    
Beginning balance at Dec. 31, 2018 28,037,774 56,427,928 0 $ 24,825 (28,670,095) 255,116
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (shares)       10,000    
Exercise of stock options 12,000 11,990   $ 10    
Stock issuance costs (611) (611)        
Stock based compensation expense 38,035 38,035        
Net income (loss) (3,280,077)       (3,280,077)  
Net loss 125,746         (125,746)
Net income (loss) (3,405,823)          
Ending balance (shares) at Mar. 31, 2019       24,834,746    
Ending balance at Mar. 31, 2019 $ 24,681,375 $ 56,477,342 $ 0 $ 24,835 $ (31,950,172) $ 129,370